These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24425833)

  • 1. Effect of thioridazine on experimental cutaneous staphylococcal infections.
    Hahn BL; Sohnle PG
    In Vivo; 2014; 28(1):33-8. PubMed ID: 24425833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of thioridazine and dicloxacillin as a possible treatment strategy of staphylococci.
    Rasmussen KS; Poulsen MØ; Jacobsen K; Skov MN; Kolmos HJ; Kallipolitis BH; Klitgaard JK
    New Microbiol; 2017 Apr; 40(2):146-147. PubMed ID: 28255602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.
    Kristiansen MM; Leandro C; Ordway D; Martins M; Viveiros M; Pacheco T; Molnar J; Kristiansen JE; Amaral L
    In Vivo; 2006; 20(3):361-6. PubMed ID: 16724671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Drug Resistance of
    Luan W; Liu X; Wang X; An Y; Wang Y; Wang C; Shen K; Xu H; Li S; Liu M; Yu LU
    Pol J Microbiol; 2019 Dec; 68(4):477-491. PubMed ID: 31880892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioridazine potentiates the effect of a beta-lactam antibiotic against Staphylococcus aureus independently of mecA expression.
    Poulsen MØ; Jacobsen K; Thorsing M; Kristensen NR; Clasen J; Lillebæk EM; Skov MN; Kallipolitis BH; Kolmos HJ; Klitgaard JK
    Res Microbiol; 2013; 164(2):181-8. PubMed ID: 23089256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities.
    Cohen PR
    South Med J; 2005 Jun; 98(6):596-602. PubMed ID: 16004165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with thioridazine and dicloxacillin combats meticillin-resistant Staphylococcus aureus infection in Caenorhabditis elegans.
    Poulsen MØ; Schøler L; Nielsen A; Skov MN; Kolmos HJ; Kallipolitis BH; Olsen A; Klitgaard JK
    J Med Microbiol; 2014 Sep; 63(Pt 9):1174-1180. PubMed ID: 24913562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse Model of Staphylococcus aureus Skin Infection.
    Malachowa N; Kobayashi SD; Lovaglio J; DeLeo FR
    Methods Mol Biol; 2019; 1960():139-147. PubMed ID: 30798528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat
    Sun M; Zhu C; Long J; Lu C; Pan X; Wu C
    Drug Deliv; 2020 Dec; 27(1):632-641. PubMed ID: 32329376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study.
    Martins M; Bleiss W; Marko A; Ordway D; Viveiros M; Leandro C; Pacheco T; Molnar J; Kristiansen JE; Amaral L
    In Vivo; 2004; 18(6):787-94. PubMed ID: 15646821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections.
    Szczesiul JM; Shermock KM; Murtaza UI; Siberry GK
    Pediatr Infect Dis J; 2007 Sep; 26(9):852-4. PubMed ID: 17721387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous erysipelas caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Del Giudice P; Blanc-Amrane V
    Dermatology; 2007; 214(2):191-2; author reply 192-3. PubMed ID: 17341875
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model.
    Kernodle DS; Kaiser AB
    Antimicrob Agents Chemother; 1993 Apr; 37(4):702-7. PubMed ID: 8494364
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    McCurdy S; Lawrence L; Quintas M; Woosley L; Flamm R; Tseng C; Cammarata S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
    Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
    J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners.
    Cohen PR
    Am J Clin Dermatol; 2007; 8(5):259-70. PubMed ID: 17902728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro.
    Kristiansen MM; Leandro C; Ordway D; Martins M; Viveiros M; Pacheco T; Kristiansen JE; Amaral L
    Int J Antimicrob Agents; 2003 Sep; 22(3):250-3. PubMed ID: 13678829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus.
    Gorwitz RJ
    Clin Infect Dis; 2007 Mar; 44(6):785-7. PubMed ID: 17304448
    [No Abstract]   [Full Text] [Related]  

  • 20. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ; Smith N; Bradsher RW; Menon A
    Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.